Study S000244

Clinical Study Comparing Time to Glucose Attainment in Patients With Type 2 Diabetes Mellitus Treated With Degu Insulin Liraglutide Injection Versus Premixed Insulin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06925334
Acronym: TLI vs PMI
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: ENROLLING_BY_INVITATION
Enrollment: 170
Start: 2024-05-20
Primary completion: 2025-12-31
Lead sponsor: Beijing Tsinghua Chang Gung Hospital
Conditions: Type 2 Diabetic Patients
Interventions: DRUG:Degludec insulin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Time to blood glucose compliance [From the time of enrollment and signing of informed consent, the program started when blood glucose was controlled at 7.5 mmol/l for 14 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.